• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

加强非洲大陆的疫苗能力建设。

Strengthening vaccine capacity building on the African continent.

出版信息

Nat Commun. 2025 Aug 13;16(1):7525. doi: 10.1038/s41467-025-62839-y.

DOI:10.1038/s41467-025-62839-y
PMID:40804064
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12350677/
Abstract

The African Union (AU) has set an ambitious goal to strengthen primary health care systems on the African continent and achieve universal health coverage for all African citizens by 2030. As part of this initiative, the AU advocates for African self-reliance in the manufacturing of life-saving vaccines and drugs. Here, we speak with Professor Nicaise Ndembi and Dr Jerome Kim, who are at the forefront of capacity building for African vaccine manufacturing, about the progress that has been made towards the AU’s goal, and what challenges remain.

摘要

非洲联盟(非盟)设定了一个雄心勃勃的目标,即加强非洲大陆的初级卫生保健系统,并在2030年前为所有非洲公民实现全民健康覆盖。作为该倡议的一部分,非盟倡导非洲在生产救命疫苗和药品方面实现自力更生。在此,我们采访了处于非洲疫苗生产能力建设前沿的尼凯斯·恩登比教授和杰罗姆·金博士,了解在实现非盟目标方面取得的进展以及仍然存在的挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/12350677/15e880be1ac6/41467_2025_62839_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/12350677/15e880be1ac6/41467_2025_62839_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3431/12350677/15e880be1ac6/41467_2025_62839_Figa_HTML.jpg

相似文献

1
Strengthening vaccine capacity building on the African continent.加强非洲大陆的疫苗能力建设。
Nat Commun. 2025 Aug 13;16(1):7525. doi: 10.1038/s41467-025-62839-y.
2
Contribution of polio eradication initiative to strengthening routine immunization: Lessons learnt in the WHO African region.根除脊髓灰质炎倡议对加强常规免疫的贡献:世卫组织非洲区域的经验教训
Vaccine. 2016 Oct 10;34(43):5187-5192. doi: 10.1016/j.vaccine.2016.05.062. Epub 2016 Jul 7.
3
African-led health research and capacity building- is it working?非洲主导的卫生研究和能力建设——它有效吗?
BMC Public Health. 2020 Jul 14;20(1):1104. doi: 10.1186/s12889-020-08875-3.
4
Approaches and impact of non-academic research capacity strengthening training models in sub-Saharan Africa: a systematic review.撒哈拉以南非洲非学术研究能力强化培训模式的方法与影响:一项系统综述
Health Res Policy Syst. 2015 Jun 9;13:30. doi: 10.1186/s12961-015-0017-8.
5
A capacity strengthening model toward self-reliant and sustainable one-health workforce in six East African Community Partner States.在东非共同体六个伙伴国建立一支自力更生、可持续的一体化健康劳动力队伍的能力加强模式。
Front Public Health. 2025 Jul 24;13:1636817. doi: 10.3389/fpubh.2025.1636817. eCollection 2025.
6
Building global vaccine manufacturing capacity: Spotlight on Africa.构建全球疫苗制造能力:聚焦非洲。
Vaccine. 2023 Jun 19;41(27):4050-4056. doi: 10.1016/j.vaccine.2023.05.009. Epub 2023 May 11.
7
Eliciting initial programme theories for a health research capacity strengthening initiative targeting African universities: A realist synthesis.为一项针对非洲大学的卫生研究能力加强倡议引出初始项目理论:一项实在论综合分析
PLoS One. 2025 Aug 20;20(8):e0330360. doi: 10.1371/journal.pone.0330360. eCollection 2025.
8
A continent-wide effort and solidarity at curbing COVID-19 pandemic: the Africa task force for novel coronavirus (AFTCOR) infection prevention and control technical working group's experience.全大陆共同努力和团结遏制 COVID-19 大流行:非洲新型冠状病毒感染预防和控制技术工作组的经验。
BMC Public Health. 2023 May 15;23(1):893. doi: 10.1186/s12889-023-15706-8.
9
"We need more big trees as well as the grass roots": going beyond research capacity building to develop sustainable careers in mental health research in African countries.“我们既需要大树,也需要草根”:超越研究能力建设,在非洲国家发展可持续的心理健康研究职业。
Int J Ment Health Syst. 2020 Aug 14;14:66. doi: 10.1186/s13033-020-00388-1. eCollection 2020.
10
Strengthening Vaccine Safety Systems, Research, and Regional Collaboration in Africa: A Call to Action.加强非洲的疫苗安全系统、研究与区域合作:行动呼吁。
Vaccines (Basel). 2025 Jun 19;13(6):661. doi: 10.3390/vaccines13060661.

本文引用的文献

1
Bridging the vaccine divide.弥合疫苗差距。
Nat Med. 2025 Jun;31(6):1737. doi: 10.1038/s41591-025-03728-1.
2
Advancing local manufacturing capacities for vaccines within Africa - Opportunities, priorities and challenges.提升非洲本土疫苗生产能力——机遇、优先事项与挑战
Vaccine. 2025 Mar 19;50:126829. doi: 10.1016/j.vaccine.2025.126829. Epub 2025 Feb 5.
3
African leadership is critical in responding to public health threats.非洲的领导层在应对公共卫生威胁方面至关重要。
Nat Commun. 2024 Jan 29;15(1):877. doi: 10.1038/s41467-024-45220-3.
4
Impact of serogroup A meningococcal conjugate vaccine for Africa.非洲 A 群脑膜炎球菌结合疫苗的影响。
Hum Vaccin Immunother. 2018 May 4;14(5):1116-1117. doi: 10.1080/21645515.2017.1412022. Epub 2018 Jan 16.
5
Impact of MenAfriVac in nine countries of the African meningitis belt, 2010-15: an analysis of surveillance data.《2010-2015 年非洲脑膜炎带九个国家 MenAfriVac 的影响:监测数据分析》
Lancet Infect Dis. 2017 Aug;17(8):867-872. doi: 10.1016/S1473-3099(17)30301-8. Epub 2017 May 22.
6
Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India.在产品开发伙伴关系中开发A群脑膜炎球菌结合疫苗时面临的挑战与机遇:来自印度血清研究所制造商的视角
Clin Infect Dis. 2015 Nov 15;61 Suppl 5(Suppl 5):S483-8. doi: 10.1093/cid/civ500.